2017-08-02 San Diego: Collidion Acquires 80% Stake in Plex Pharmaceuticals
2015-05-05 San Diego: Plex Pharmaceuticals awarded Phase I SBIR grant to treat Dengue virus infection.
2013-06-13 San Diego: Plex’s Chairman, Allan E. Rubenstein MD, co-authors a ground-breaking peer reviewed scientific manuscript demonstrating the utility Heat Shock Protein 90 (Hsp90) inhibitors for the treatment of Neurofibromatosis type 2 (NF2).
2012-02-12 San Diego: Plex Pharmaceuticals and Professor R. Padmanabhan of Georgetown University announce a collaboration to develop inhibitors of Dengue and West Nile virus proteases.
2011-12-07 San Diego: Plex and LD Biopharma Have Agreed to Provide Integrated Discovery Services for structure-based and fragment-based drug discovery.
2010-09-10 San Diego: Plex receives a $279,068 grant award to develop selective and dual-acting HSP90 and TRAP1 inhibitors
2010-06-07 San Diego: Plex receives a $549,882 grant award to develop novel, selective and potent brain-penetrable small molecule cytosolic Hsp90 inhibitors
2010-05-05 San Diego: Plex receives a $201,930 grant award to develop glucose-dependent partial activators of pancreatic glucokinase